ArticleFrontiers in oncology2021

A Novel Combined Conjugate Therapeutic Cancer Vaccine, Recombinant EGF-CRM197, in Patients With Advanced Solid Tumors: A Phase I Clinical Study.

An-Wen Xiong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.